Factors affecting outcome in renal cell carcinoma

被引:7
|
作者
Sun, Maxine [1 ]
Shariat, Shahrokh F. [2 ]
Karakiewicz, Pierre I. [1 ,3 ]
机构
[1] Univ Montreal, Ctr Hlth, Canc Prognost & Hlth Outcomes Unit, Montreal, PQ H2X 3J4, Canada
[2] Weill Cornell Med Ctr, Dept Urol, New York, NY USA
[3] Univ Montreal, Ctr Hlth, Dept Urol, Montreal, PQ H2X 3J4, Canada
关键词
outcome; prognostic factors; renal cell carcinoma; INTEGRATED STAGING SYSTEM; POSTOPERATIVE PROGNOSTIC NOMOGRAM; ENDOTHELIAL GROWTH-FACTOR; CANCER-SPECIFIC SURVIVAL; INTERFERON-ALPHA; PREDICT SURVIVAL; MULTIINSTITUTIONAL VALIDATION; SARCOMATOID DIFFERENTIATION; STRATIFICATION TOOL; SEQUENTIAL THERAPY;
D O I
10.1097/MOU.0b013e32833c7b19
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose of review To review the latest status on prognostic factors in renal cell carcinoma (RCC). Recent findings Many predictive and prognostic factors can help differentiate between favorable and unfavorable RCC phenotypes. There currently exist several clinical and/or pathological, and biological factors, which have been exclusively tested and used in predictive and prognostic models. Nonetheless, the search for highly informative and reliable factors of disease characteristics and progression continues. Conclusion Over the last decade, an increase occurred in the number of models that can predict the treated natural history of RCC. Many of these novel models and previously developed models are tested in a head-to-head fashion, with the intent of identifying the most accurate and valuable tools for clinical practice. Novel prognostic factors and more upto-date models are urgently needed for patients with metastatic RCC, especially in the era of targeted therapies. This should represent the focus of contemporary prognostic modeling in RCC.
引用
收藏
页码:355 / 360
页数:6
相关论文
共 50 条
  • [31] Leukopenia as a Biomarker of Sunitinib Outcome in Advanced Renal Cell Carcinoma
    Fujita, Tetsuo
    Wakatabe, Yoji
    Matsumoto, Kazumasa
    Tabata, Ken-Ichi
    Yoshida, Kazunari
    Iwamura, Masatsugu
    ANTICANCER RESEARCH, 2014, 34 (07) : 3781 - 3787
  • [32] Chromophobe Renal Cell Carcinoma: The Impact of Tumor Grade on Outcome
    Cheville, John C.
    Lohse, Christine M.
    Sukov, William R.
    Thompson, Robert Houston
    Leibovich, Bradley C.
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2012, 36 (06) : 851 - 856
  • [33] Prognostic Factors in Patients With Advanced Renal Cell Carcinoma
    Muriel Lopez, Carolina
    Esteban, Emilio
    Pablo Berros, Jose
    Pardo, Pablo
    Astudillo, Aurora
    Izquierdo, Marta
    Crespo, Guillermo
    Sanmamed, Miguel
    Fonseca, Paula J.
    Martinez-Camblor, Pablo
    CLINICAL GENITOURINARY CANCER, 2012, 10 (04) : 262 - 270
  • [34] The use of prognostic factors in metastatic renal cell carcinoma
    Li, Haoran
    Samawi, Haider
    Heng, Daniel Y. C.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2015, 33 (12) : 509 - 516
  • [35] Prognostic factors associated with the response to sunitinib in patients with metastatic renal cell carcinoma
    Yildiz, I.
    Sen, F.
    Kilic, L.
    Ekenel, M.
    Ordu, C.
    Kilicaslan, I.
    Darendeliler, E.
    Tunc, H. M.
    Varol, U.
    Bavbek, S.
    Basaran, M.
    CURRENT ONCOLOGY, 2013, 20 (06) : E546 - E553
  • [36] Factors impacting survival in children with renal cell carcinoma
    Rialon, Kristy L.
    Gulack, Brian C.
    Englum, Brian R.
    Routh, Jonathan C.
    Rice, Henry E.
    JOURNAL OF PEDIATRIC SURGERY, 2015, 50 (06) : 1014 - 1018
  • [37] Nonfocal Renal Biopsies: Adequacy and Factors Affecting a Successful Outcome
    Goldstein, Mark A.
    Atri, Mostafa
    O'Malley, Martin
    Jacks, Lindsay
    John, Rohan
    Herzenberg, Andrew
    Reich, Heather
    Ghai, Sangeet
    JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 2013, 37 (02) : 176 - 182
  • [38] Prognostic factors of renal cell carcinoma: A multivariate analysis
    Yasunaga, Y
    Shin, M
    Miki, T
    Okuyama, A
    Aozasa, K
    JOURNAL OF SURGICAL ONCOLOGY, 1998, 68 (01) : 11 - 18
  • [39] Current Management of Advanced and Metastatic Renal Cell Carcinoma
    Ather, M. Hammad
    Masood, Nehal
    Siddiqui, Tahmeena
    UROLOGY JOURNAL, 2010, 7 (01) : 1 - 9
  • [40] Risk models for patients with localised renal cell carcinoma
    Velis, J. M.
    Ancizu, F. J.
    Hevia, M.
    Merino, I.
    Garcia, A.
    Domenech, P.
    Algarra, R.
    Tienza, A.
    Pascual, J. I.
    Robles, J. E.
    ACTAS UROLOGICAS ESPANOLAS, 2017, 41 (09): : 564 - 570